Browse > Article

Regulatory effects of Seogakjihwang-tang on Cytokines and Growth Factor Production in PBMC from the Patient with Cerebral infarction under Consciousness Disorders  

Kim Yo Han (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University)
Sung Kang Keyng (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University)
Lee Kwang Ro (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University)
Lee Sang Kwan (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University)
Cheong Sang Su (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University)
Kang Sei Young (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University)
Lee So Young (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.17, no.3, 2003 , pp. 829-836 More about this Journal
Abstract
Seogakjihwang-tang (SJT) was widely used to treat patients suffering from cerebral infarction. But scientific investigation has been carried out very little. The aim of the present study is to investigate the effect of SJT on the production of various cytokines in the patients with cerebral infarction (CI). We investigated interleukin (IL)-4, IL-10 and transforming growth factor (TGF)-1 in the sera of 27 patients with cerebral infarction under consciousness disorders and 10 normal controls using an originally devised sensitive sandwich enzyme-linked immunosorbent assay (ELISA). We found that plasma levels of IL-4 were slightly elevated in patients with cerebral infarction, whereas plasma levels of IL-10 (P<0.001) and TGF-1 were reduced. Peripheral blood mononuclear cells (PBMC) obtained from the patient with CI were cultured for 24 h in the presence or absence of lipopolysaccharide (LPS) or phytohaemagglutinin (PHA). The amount of IL-4, IL-10 and TGF-1, in culture supernatant, was significantly increased in the LPS or PHA treated cells compared to unstimulated cells (P<0.05), We also show that increased cytokines IL-4, and IL-10 level was significantly inhibited by SJT in a dose-dependent manner. Maximal inhibition rate of IL-4 and IL-10 production by SJT was 45.63.3% and 614.7% for LPS-stimulated cell and 27.31.2% and 83.62% for PHA-stimulated cells, respectively (P<0.05). On the other hand, SJT significantly increased the LPS or PHA-induced TGF-1 production (P<0.05). These data suggest that SJT has a regulatory effect on the cytokines production, which might explain its beneficial effect in the treatment of CI.
Keywords
Seogakjihwang-tang(遲角); Cytokines; Lipopolysaccharide; Cerebral infarction; Phytohaemagglutinin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis. /
[ Matsunaga Y;Kawasaki H;Terada T ] / Am J Gastroenterol
2 Transforming growth factor-beta in disease: the dark side of tissue repair. /
[ Border WA;Ruoslahti E ] / F Clin Invest
3 Hypothesis: a role for tumor necrosis factor in immune-related demyelination and its relevance to multiple sclerosis. /
[ Brosnan CF;Selmaj FK;Raine DS ] / J. Neuroimmunol
4 Reduced IL-2 but elevated IL-4, IL-6 and IgE serum levels in patients with cerebral infarction during the acute stage. /
[ Kim HM;Shin HY;Jeong HJ;An HJ;Kim NS;Chae HJ;Kim HR;Song HJ;Kim KY;Baek SH;Cho KH;Moon BS;Lee YM ] / J. Mol. Neurosci
5 Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. /
[ Knoblach Susan M ] / Experimental Neurology
6 Human TH1 and TH2 subsets: doubt no more. /
[ Romagnani S ] / Immunol Today
7 Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease. /
[ Saltis J;Agrotis A;Bobik A ] / Clin Exp Pharmacol Physlol
8 Toxicity of dimethyl sulfoxide as a solvent in bioassay system with HeLa cells evaluated colorimetrically with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide. /
[ Ben Trivedi A;Kitabatake N;Doi E ] / Agric Blol Chem
9 /
[ Kenneth W. Lindsay;Ian Bone ] / Clinical neurology
10 Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. /
[ Parronchi P;Macchia D;Piccinni MP;Biswas P;Simonelli C;Maggi E;Ricci M;Ansari AA;Romagnani S ] / Proc Natl Acad Sci U S A
11 Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. /
[ Zurawski C;de Vries JE ] / Immunol Today
12 Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin inflammation. /
[ Alenius H;Laouini D;Woodward A;Mizoguchi E, Bhan AK;Castigli E;Oettgen HC;Geha RS ] / J Allergy Clin Immunol
13 Reduced IL-2 but elevated IL-4, IL-6, and IgE serum levels in patients with cerebral infarction during the acute stage. /
[ Kim HM;Shin HY;Jeong HJ;An HJ;Kim NS;Chae HJ;Kim HR;Song HJ;Kim KY;Baek SH;Cho KH;Moon BS;Lee YM ] / J Mol Neurosci
14 Regulatory effect of cytokine production in asthma patients by SOOJI CHIM(Koryo Hand Acupuncture Therapy). /
[ Jeong HJ;Kim BS;Kim KS;Kim HM ] / Immunopharmacol Immunotoxicol
15 Functions of IL-4 and control of its expression. /
[ Brown MA;Hural J ] / Crit Rev Immunol
16 Cytokine production regulation in human astrocytes by a herbal combination (Yuldahansotang). /
[ Choi JS;Jung SW;Ju JC;Lee SW;Kim KY;Kim HM ] / Immunopharmacol Immunotoxicol   ScienceOn
17 IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. /
[ Gazzinelli RT;Oswald IP;James SL;Sher A ] / J Immunol
18 High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. /
[ Pelidou SH;Kostulas N;Matusevicius D;Kivisakk P;Kostulas V;Link H ] / Eur J Neurol
19 IL-10 reduces rat brain injury following focal stroke. /
[ Spera PA;Ellison JA;Feuerstein GZ;Barone FC ] / Neurosci Lett
20 Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. /
[ Krupinski J;Kunlar P;Kumar S;Kaluza J ] / Stroke   ScienceOn
21 Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. /
[ Zhu Y;Yang GY;Ahlemeyer B;Pang L;Che XM;Culmsee C;Klumpp S;Krieglstein J ] / J Neurosci
22 A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. /
[ Krupinski J;Issa R;Bujny T;Slevin M;Kumar P;Kumar S;Kaluza J ] / Stroke   ScienceOn
23 Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. /
[ Wang Y;Chang CF;Morales M;Chiang YH;Hoffer J ] / Ann N Y Acad Sci
24 Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. /
[ Kawamata T;Dietrirh WD;Schallert T;Gotts JE;Cocke RR;Benowitz LI;Finklestein SP ] / Proc Natl Acad Sci USA
25 Expression of transforming growth factor-beta 1 and interleukin-1 beta mRNA in rat brain following transient forebrain ischemia. /
[ Wiessner C;Gehrmann J;Lindholm D;Topper R;Kreutzberg GW;Hossmann KA ] / Acta Neuropathol (Ber1)
26 Activation of human macrophages. Comparison of other cytokines with interferon-gamma. /
[ Nathan GF;Prendergast TJ;Wiebe ME;Stanley ER;Platzer E;Remold HG;Welte K;Rubin BY;Murray HW ] / J Exp Med
27 Interactions of epidermal cells and T cells in inflammatory skin diseases. /
[ Baadsgaard O;Fisher GJ;Voorhees JJ;Cooper KD ] / J Am Acad Dermatol
28 Interleukin-4: a prototypic immunoregulatory lymphokine. /
[ Paul WE ] / Blood
29 Promotion of human T lymphocyte proliferation by IL-4. /
[ Mitchell LC;Davis LS;Lipsky PE ] / J Immunol
30 Interleukin-4 (IL4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. /
[ te Velde AA;Huijbens RJ;Heije K;de Vries JE;Figdor CG ] / Blood
31 Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-gamma. /
[ Howells G;Pham P;Taylor D;Foxwell B;Feldmann M ] / Eur J Immunol
32 Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. /
[ Sempowski GD;Beckmann MP;Derdak S;Phipps RP ] / J Immunol
33 Synthesis of cytokines by eosinophils and their regulation. /
[ Lamkhioued B;Aldebert D;Gounni AS;Delaporte E;Goldman M;Capron A;Capron M ] / Int Arch Allergy Immunol
34 Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. /
[ de Waal Malefyt R;Abrams J;Bennett B;Figdor CG; de Vries JE ] / J Exp Med
35 Analysis of transforming growth factor-beta 1 (TGF-beta1) expression in human monocytes infected with Mycobacterium avium at a single tell level by ELISPOT assay. /
[ Aung H;Sherman J;Tary-Lehman M;Toossi Z ] / J Immunol Methods
36 Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. /
[ Geng Y;Gulbins E;Altman A;Lotz M ] / Proc Natl Acad Sci U S A
37 Biological properties of interleukin 10. /
[ Howard M;O'Garra A ] / Immunol Today
38 Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. /
[ Le Moine O;Louis H;Demols A;Desalle F;Demoor F;Quertinmont E;Goldman M;Deviere J ] / Hepatology.
39 Induction of cardiac fibrosis by transforming growth factor-beta(1). /
[ Lijnen PJ;Petrov W;Fagard RH ] / Mol Genet Metab
40 Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. /
[ Perini F;Morra M;Alecci M;Galloni E;Marchi M;Toso V ] / Neutol Sci